Nucleus RadioPharma seeks to ensure cancer patients can access potentially life-saving radiopharmaceuticals by developing technologies to modernize the clinical development, manufacturing, and supply chain of these promising new therapies.
| Date | Amount | Type | Investors | Valuation |
|---|---|---|---|---|
| 10/12/22 | $6,000,000 | Seed |
Eclipse Ventures Mayo Clinic | undisclosed |
| 10/17/23 | $56,000,000 | Series A |
Echo Global Eclipse Ventures  Fox Chase Cancer Center GE Healthcare Granger Management Mayo Clinic Mercy Health of Cincinnati University of Missouri | undisclosed |
| 06/05/24 | undisclosed | Series A Extension |
AstraZeneca | undisclosed |
